首页> 美国卫生研究院文献>Radiation Oncology (London England) >No difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction
【2h】

No difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction

机译:在有或没有乳房植入物重建的情况下乳房切除术后放疗中有风险器官的剂量分布没有差异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to quantify the variation in doses to organs at risk (ipsilateral lung and heart) and the clinical target volume (CTV) in the presence of breast implants. In this retrospective cohort study, patients were identified through the National Breast Cancer Register. Consecutive breast cancer patients undergoing mastectomy between 2009 and 2011 and completing a full course of postmastectomy radiotherapy (PMRT) were eligible. All included patients (n = 818) were identified in the ARIA© oncology information system and further stratified for immediate breast reconstruction (IBR+, n = 162) and no immediate breast reconstruction (IBR-, n = 656). Dose statistics for ipsilateral lung, heart and CTV were retrieved from the system. Radiation plans for patients with chest wall (CW) only (n = 242) and CW plus lymph nodes (n = 576) irradiation were studied separately.The outcome variables were dichotomized as follows: lung, V20Gy ≤ 30% vs. V20Gy > 30%; heart, Dmean ≤ 5 Gy vs. Dmean > 5 Gy; CTV, V95% ≥ median vs. V95% < median.In the univariate and multivariate regression models no correlation between potential confounders (i.e. breast reconstruction, side of PMRT, CW index) and the outcome variables was found. Multivariate analysis of CW plus lymph nodes radiation plans, for example, showed no association of breast reconstruction with dosimetric outcomes in neither lung nor heart- lung V20Gy (odds ratio [OR]: 0.6, 95%CI, 0.4 to 1.0, p = 0.07) or heart Dmean (OR: 1.2, 95%CI, 0.5 to 3.1, p = 0.72), respectively.CTV was statistically significantly larger in the IBR+ group (i.e. included breast implant), but no correlation between the implant type and dosimetric characteristics of the organs at risk was revealed.In the current study, the presence of breast implants during postmastectomy radiotherapy was not associated with increased doses to ipsilateral lung and heart, but CTV definition and its dosimetric characteristics urge further evaluation.
机译:这项研究的目的是量化存在乳房植入物的情况下,处于危险中的器官(同侧肺和心脏)的剂量和临床目标体积(CTV)的变化。在这项回顾性队列研究中,通过美国国家乳腺癌登记簿确定了患者。在2009年至2011年间接受乳房切除术并完成整个乳房切除术放疗(PMRT)的连续性乳腺癌患者符合资格。在ARIA©肿瘤学信息系统中识别出所有纳入的患者(n = 818),并进一步分层以立即进行乳房再造(IBR +,n = 162),而不进行立即乳房再造(IBR-,n = 656)。从系统中检索了同侧肺,心脏和CTV的剂量统计数据。分别研究了仅胸壁(nw = 242)和连续波加淋巴结(n = 576)的患者的放射计划,结果变量分为两部分:肺,V20Gy≤30%vs V20Gy> 30 %;心,Dmean≤5 Gy vs Dmean> 5 Gy; CTV,V95%≥中位数vs V95%≤中位数在单变量和多元回归模型中,未发现潜在混杂因素(即乳房重建,PMRT一侧,CW指数)与结果变量之间的相关性。例如,对CW加淋巴结放疗计划的多变量分析显示,在肺和心肺V20Gy中,乳房重建与剂量学结局均无关联(优势比[OR]:0.6、95%CI,0.4至1.0,p = 0.07) )或心脏Dmean(OR:1.2,95%CI,0.5至3.1,p = 0.72).IBR +组(即包括乳房植入物)的CTV在统计学上显着较大,但植入物类型与剂量特性之间无相关性在当前的研究中,乳房切除术后放疗期间乳房植入物的存在与同侧肺和心脏的剂量增加无关,但是CTV的定义及其剂量学特征需要进一步评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号